This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Covid-19 vaccine developers in contract talks with generic drug producers, trade group tells USITC panel

By Kat Lucero ( September 23, 2020, 22:52 GMT | Insight) -- Some generic drugmakers are currently in discussions with major pharmaceutical drug producers working on a vaccine for the novel coronavirus, to help meet demand, an executive for the Association for Accessible Medicines said. Some generic drugmakers are currently in discussions with major pharmaceutical drug producers working on a vaccine for the novel coronavirus, to help meet demand, an executive for the Association for Accessible Medicines said today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections